Fund shareholders of THERIVA BIOLOGICS INC
ISIN US87164U5083 · United States · LEI 529900RVC1I52VWB3G55
- Fund shareholders
- 4
- Of which ETFs
- 0 4 other funds
- Value held
- 81.4K $
- Share of capital
- 0.9 % of 45.9M shares on Aug 7, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 192,565 | 38.5K $ | 0.00 % | 0.42 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 192,404 | 37.7K $ | 0.42 % | as of Mar 31, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 26,070 | 5.2K $ | 0.06 % | as of Feb 28, 2026 ↗ | |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 31 | 6.1 $ | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 4 | 0 | 411,070 | +976.6 % |
| 2026Q1 | 4 | -1 | 38,182 | -2.0 % |
| 2025Q4 | 5 | 0 | 38,972 | +52.5 % |
| 2025Q3 | 5 | 0 | 25,559 | +60.1 % |
| 2025Q2 | 5 | 0 | 15,967 | +16.7 % |
| 2025Q1 | 5 | 0 | 13,683 | +10.9 % |
| 2024Q4 | 5 | 12,334 |
Institutional managers
18 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 450,263 | 88.2K $ | as of Mar 31, 2026 |
| Virtu Financial LLC | 253,218 | 50 $ | as of Mar 31, 2026 |
| UBS Group AG | 225,624 | 44.2K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 177,034 | 34.7K $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 112,076 | 21.9K $ | as of Mar 31, 2026 |
| TWO SIGMA SECURITIES, LLC | 105,241 | 20.6K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 94,620 | 18.5K $ | as of Mar 31, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 27,646 | 5.4K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 23,602 | 4.6K $ | as of Mar 31, 2026 |
| StoneX Group Inc. | 22,280 | 4.4K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 15,441 | 3K $ | as of Mar 31, 2026 |
| SCHWARZ DYGOS WHEELER INVESTMENT ADVISORS LLC | 15,000 | 2.9K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 7,504 | 1.5K $ | as of Mar 31, 2026 |
| CITIGROUP INC | 1,391 | 272 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 131 | 26 $ | as of Mar 31, 2026 |
| IFP Advisors, Inc | 11 | 2 $ | as of Mar 31, 2026 |
| NFSG Corp | 5 | 1 $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 3 | 1 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of THERIVA BIOLOGICS INC". https://titelia.com/en/stocks/theriva-biologics-inc-US87164U5083